Your browser doesn't support javascript.
loading
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial.
Davey, Richard T; Fernández-Cruz, Eduardo; Markowitz, Norman; Pett, Sarah; Babiker, Abdel G; Wentworth, Deborah; Khurana, Surender; Engen, Nicole; Gordin, Fred; Jain, Mamta K; Kan, Virginia; Polizzotto, Mark N; Riska, Paul; Ruxrungtham, Kiat; Temesgen, Zelalem; Lundgren, Jens; Beigel, John H; Lane, H Clifford; Neaton, James D.
Afiliación
  • Davey RT; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA. Electronic address: rdavey@niaid.nih.gov.
  • Fernández-Cruz E; Hospital General Universitario Gregorio Marañón, Servicio de Immunología Clínica, Madrid, Spain.
  • Markowitz N; Henry Ford Hospital, Division of Infectious Diseases, Detroit, MI, USA.
  • Pett S; Medical Research Council Clinical Trials Unit, University College London, London, UK.
  • Babiker AG; Medical Research Council Clinical Trials Unit, University College London, London, UK.
  • Wentworth D; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
  • Khurana S; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Engen N; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
  • Gordin F; Veteran Affairs Medical Center, Washington, DC, USA.
  • Jain MK; UT Southwestern Medical Center, Dallas, TX, USA.
  • Kan V; Veteran Affairs Medical Center, Washington, DC, USA.
  • Polizzotto MN; The Kirby Institute, University of New South Wales Australia, Sydney, NSW, Australia.
  • Riska P; Montefiore Medical Center, Bronx, NY, USA.
  • Ruxrungtham K; Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; The HIV Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
  • Temesgen Z; Mayo Clinic Hospital, Saint Marys Campus, Rochester, MN, USA.
  • Lundgren J; CHIP Centre of Excellence for Health, Immunity, and Infections, Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
  • Beigel JH; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Lane HC; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Neaton JD; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Lancet Respir Med ; 7(11): 951-963, 2019 11.
Article en En | MEDLINE | ID: mdl-31582358
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antivirales / Virus de la Influenza A / Inmunoglobulinas Intravenosas / Betainfluenzavirus / Gripe Humana Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Lancet Respir Med Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antivirales / Virus de la Influenza A / Inmunoglobulinas Intravenosas / Betainfluenzavirus / Gripe Humana Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Lancet Respir Med Año: 2019 Tipo del documento: Article